India Active Pharmaceutical Ingredients(APIs) Industry Report, 2008-2009

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) June 5, 2009 -- India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR as high as 18.81% during 2003-2007. And Indian ranks at the fourth in the world in terms of API output.

India currently has about 3000 API factories and 5,000 reagent factories, the key API producers including the Ranbaxy, Dr. Reddy, Cipla Ltd, Cadila Healthcare and Matrix. They are producing more than 400 sorts of API and around 10,000 kinds of reagents, satisfying over 90% of Indian domestic demand.

The pharmaceutical companies such as Dr.Reddy, Wockhardt and Sun Pharmaceuticals are also producing API. In the FY2007, 40% sales of Dr. Reddy were contributed by the API. Similarly, 19% revenues of Wockhardt and 18% revenues of Sun Pharmaceuticals were contributed by the API respectively.

The API export of India will enjoy a rapid growth in the coming years, According to the Tata Strategic Management Group, Indian API export value will increase to US $12.75 billion in 2012 from US $3.75 billion in 2007.

This report gives an in-depth analysis of 28 Indian API Producers, including their profile, operating revenues, net profit, products, market distribution and future developments etc.

For details of this report please visit http://www.researchinchina.com/Htmls/Report/2009/5677.html

Contact Information
Helen Wang
Marketing Department
www.researchinchina.com
Phone: 86-10-82600893
Email: helen.wang@researchinchina.com

APIs